Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia
Status:
Completed
Trial end date:
2009-11-18
Target enrollment:
Participant gender:
Summary
This is an open-label study to evaluate safety, tolerability, efficacy and PK profile of
ofatumumab monotherapy in Japanese follicular lymphoma (FL) or chronic lymphocytic leukemia
(CLL) patients. subject will receive ofatumumab 8 weekly infusions.